Literature DB >> 25598729

Lung transplantation: an overview of candidacy and outcomes.

Reinaldo Rampolla1.   

Abstract

BACKGROUND: Various factors must be taken into account when considering lung transplantation, including candidacy, contraindications, and outcomes.
METHODS: This article presents a review of the data and literature on lung transplantation, tracking the evolution of the treatment as it applies to different conditions, as well as an examination of patient survival rates in relation to pathology and treatment.
RESULTS: Timely referral and careful selection of candidates for lung transplantation maximize the outcomes of the procedure, resulting in a longer lifespan with improved physical health for patients.
CONCLUSION: Lung transplantation is a therapeutic option for patients with various lung diseases. Adapting treatment options and follow-up treatment to the individual patient's lifestyle and pathology optimizes patient survival rates after transplantation.

Entities:  

Keywords:  Heart-lung transplantation; lung transplantation

Year:  2014        PMID: 25598729      PMCID: PMC4295741     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  28 in total

1.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Derek Weycker; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Lisa Lancaster; Paul W Noble; Ganesh Raghu; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

2.  Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.

Authors:  Adaani E Frost; David B Badesch; Dave P Miller; Raymond L Benza; Leslie A Meltzer; Michael D McGoon
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

3.  Development of the new lung allocation system in the United States.

Authors:  T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

4.  Predicting mortality in patients with sarcoidosis awaiting lung transplantation.

Authors:  Andrew F Shorr; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

5.  Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease.

Authors:  H Groen; W van der Bij; G H Koëter; E M TenVergert
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

6.  Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.

Authors:  Kevin R Flaherty; Jeanette A Mumford; Susan Murray; Ella A Kazerooni; Barry H Gross; Thomas V Colby; William D Travis; Andrew Flint; Galen B Toews; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

Review 7.  Sarcoidosis-associated pulmonary hypertension.

Authors:  Francis C Cordova; Gilbert D'Alonzo
Journal:  Curr Opin Pulm Med       Date:  2013-09       Impact factor: 3.155

8.  Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.

Authors:  Margaret W Gerbase; Paola M Soccal; Anastase Spiliopoulos; Laurent P Nicod; Thierry Rochat
Journal:  J Heart Lung Transplant       Date:  2008-06-10       Impact factor: 10.247

Review 9.  Should we perform bilateral-lung or heart–lung transplantation for patients with pulmonary hypertension?

Authors:  Anne Olland; Pierre-Emmanuel Falcoz; Mathieu Canuet; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

Review 10.  Chronic allograft dysfunction.

Authors:  Christiane Knoop; Marc Estenne
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

View more
  4 in total

1.  Recent Publications by Ochsner Authors.

Authors: 
Journal:  Ochsner J       Date:  2015

2.  Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.

Authors:  Fei Gao; Jingyu Chen; Dong Wei; Bo Wu; Min Zhou
Journal:  Front Med       Date:  2017-07-28       Impact factor: 4.592

3.  Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality.

Authors:  Aria Hong; Christopher S King; A Whitney Walter Brown; Shahzad Ahmad; Oksana A Shlobin; Sandeep Khandhar; Linda Bogar; Anthony Rongione; Steven D Nathan
Journal:  Multidiscip Respir Med       Date:  2016-11-15

4.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.